Generic drug companies rework pricing to gain weight in India’s GLP-1 market as Novo Nordisk slashes Wegovy prices

This move is prompting generic companies to lower their expected launch prices. Novo Nordisk is also preparing to launch Ozempic in India soon. This competition is expected to drive down prices in the GLP-1 segment.Read More